BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36702320)

  • 1. Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis.
    Buonvicino D; Ranieri G; Guasti D; Pistolesi A; La Rocca AI; Rapizzi E; Chiarugi A
    Neurobiol Dis; 2023 Mar; 178():106015. PubMed ID: 36702320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis.
    Buonvicino D; Pratesi S; Ranieri G; Pistolesi A; Guasti D; Chiarugi A
    Neurobiol Dis; 2024 Feb; 191():106387. PubMed ID: 38142841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.
    Buonvicino D; Ranieri G; Pratesi S; Guasti D; Chiarugi A
    Exp Neurol; 2019 Dec; 322():113065. PubMed ID: 31536728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing-Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain.
    Takano C; Takano T; Masumura M; Nakamura R; Koda S; Bochimoto H; Yoshida S; Bando Y
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
    Al-Shamsi M; Shahin A; Ibrahim MF; Tareq S; Souid AK; Mensah-Brown EP
    BMC Neurosci; 2015 Jun; 16():37. PubMed ID: 26092157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
    Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
    Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis.
    Holman SP; Lobo AS; Novorolsky RJ; Nichols M; Fiander MDJ; Konda P; Kennedy BE; Gujar S; Robertson GS
    Exp Neurol; 2020 Nov; 333():113430. PubMed ID: 32745471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Mao P; Manczak M; Shirendeb UP; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ; Lee J; Nikodemova M; Fabry Z; Duncan ID
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.
    DiSano KD; Linzey MR; Royce DB; Pachner AR; Gilli F
    J Neuroinflammation; 2019 May; 16(1):109. PubMed ID: 31118079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis.
    Batoulis H; Uhl M; Addicks K; Lehmann PV; Kuerten S
    Glia; 2012 May; 60(5):794-805. PubMed ID: 22319015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M; Gold BG; Marracci G; Chaudhary P; Basso E; Johnsen D; Yu X; Fowlkes J; Rahder M; Stem K; Bernardi P; Bourdette D
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7558-63. PubMed ID: 17463082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains.
    Tsunoda I; Kuang LQ; Theil DJ; Fujinami RS
    Brain Pathol; 2000 Jul; 10(3):402-18. PubMed ID: 10885659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
    Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.